Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
2.
Int J STD AIDS ; 32(6): 582-584, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33533293

RESUMEN

Kaposi sarcoma (KS) is an angioproliferative disease that is caused by human herpesvirus 8. The epidemic form of KS is associated with acquired immunodeficiency syndrome (AIDS) and is common in HIV-positive patients with CD4 counts less than 200 cells/mm. We present the case of a 63-year-old man with well-controlled HIV and normal CD4 count developing atypical nasal KS associated with intranasal steroid use.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida , Herpesvirus Humano 8 , Sarcoma de Kaposi , Recuento de Linfocito CD4 , Humanos , Masculino , Persona de Mediana Edad , Esteroides/efectos adversos
3.
J Mol Diagn ; 9(3): 394-400, 2007 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-17591939

RESUMEN

The potential presence of maternal cell contamination (MCC) in chorionic villus or amniotic fluid samples poses a serious preanalytical risk for prenatal misdiagnosis. The aim of this study was to identify current diagnostic practices in the absence of comprehensive practice guidelines. Thirty-five clinical molecular laboratories that conduct prenatal testing agreed to participate in a clinical practice survey. The survey included questions about sample requirements, test indications, assay type, test performance and limitations, criteria and management of uninformative test results, reporting, and billing. Sixty percent of participating laboratories performed testing on direct and cultured amniotic fluid, whereas forty percent tested cultured cells only. Most also accepted chorionic villus samples. Although MCC testing of fetal samples is recommended in guidelines by the American College of Medical Genetics, only 60% of surveyed laboratories performed it without exception. Commercially available assays were used by 75% of participating laboratories, and at least five identity markers were evaluated at 87% of the laboratories. The reported lower limit of MCC detection ranged from 1 to 20% but was not determined in all laboratories. MCC testing was performed in the majority of molecular diagnostic laboratories, but guidelines for standardization are needed to ensure optimal and accurate prenatal patient care.


Asunto(s)
Artefactos , Técnicas de Laboratorio Clínico , Errores Diagnósticos/prevención & control , Intercambio Materno-Fetal , Diagnóstico Prenatal/métodos , Manejo de Especímenes/métodos , Algoritmos , Células Cultivadas , Técnicas de Laboratorio Clínico/economía , Técnicas de Laboratorio Clínico/normas , Recolección de Datos , Interpretación Estadística de Datos , Femenino , Humanos , Técnicas de Diagnóstico Molecular/normas , Pautas de la Práctica en Medicina/economía , Pautas de la Práctica en Medicina/normas , Embarazo , Diagnóstico Prenatal/economía , Diagnóstico Prenatal/normas , Sensibilidad y Especificidad , Manejo de Especímenes/normas , Encuestas y Cuestionarios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...